Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

48North Cannabis Corp. V.NRTH


Primary Symbol: NCNNF

Healthcare Drug Manufacturers - Specialty & Generic
48North Cannabis Corp is a vertically integrated cannabis company. It is focused on the health and wellness market through cultivation and extraction, as well as the creation of authentic brands for consumer-friendly products. Its products are categorized into Bath, Intimacy, Flower, Pre-roll, topical, vapes, concentrates, and accessories. It has two geographical segments: Canada, which is the key revenue driver; and the United States.


OTCPK:NCNNF - Post by User

48North Cannabis Corp. > Better article.....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(117)
•••
Comment by Blizzy420on May 23, 2020 11:01pm
301 Views
Post# 31065690

RE:Better article.....

RE:Better article.....

Just a guess on revenues....
2 million from DelShen and flower sales
50k Avitas 
50k apothecanna
 

Expenses will Exceed 5 million and cash on hand will fall close to 25 million.

thoughts?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities